Bio Green Med Solution Files 8-K/A Amendment
Ticker: BGMSP · Form: 8-K/A · Filed: Sep 17, 2025 · CIK: 1130166
Sentiment: neutral
Topics: amendment, company-name-change, other-events
Related Tickers: BGMS
TL;DR
BGMS filed an 8-K/A amendment for 'Other Events' on 9/17, amending 9/12 report.
AI Summary
Bio Green Med Solution, Inc. filed an amendment (8-K/A) on September 17, 2025, to a previous report concerning events on September 12, 2025. The filing pertains to 'Other Events' and indicates a change in the company's reporting status or information. The company, formerly known as Cyclacel Pharmaceuticals, Inc. and XCYTE THERAPIES INC, is incorporated in Delaware and headquartered in Berkeley Heights, NJ.
Why It Matters
This amendment to a Form 8-K filing suggests a correction or addition to previously reported material events, which could impact investor understanding of the company's recent activities.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings can indicate previously undisclosed or corrected material information, requiring closer investor scrutiny.
Key Players & Entities
- Bio Green Med Solution, Inc. (company) — Registrant
- September 17, 2025 (date) — Filing Date
- September 12, 2025 (date) — Date of Earliest Event Reported
- Cyclacel Pharmaceuticals, Inc. (company) — Former Company Name
- XCYTE THERAPIES INC (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- Berkeley Heights, NJ (location) — Business Address
FAQ
What specific 'Other Events' are being amended or reported in this 8-K/A filing?
The filing is an amendment to a previous report concerning 'Other Events' that occurred on or around September 12, 2025. The specific details of these events are not elaborated in the provided text.
When was the original report filed that this 8-K/A is amending?
The filing date of this 8-K/A is September 17, 2025, and it amends a report related to events on September 12, 2025. The original filing date is not explicitly stated but implied to be prior to September 17, 2025.
What were the former names of Bio Green Med Solution, Inc. and when did these name changes occur?
Bio Green Med Solution, Inc. was formerly known as Cyclacel Pharmaceuticals, Inc. (name change on March 29, 2006) and XCYTE THERAPIES INC (name change prior to December 18, 2000).
In which state is Bio Green Med Solution, Inc. incorporated and what is its primary business address?
The company is incorporated in Delaware and its business address is 200 Connell Drive, Suite 1500, Berkeley Heights, NJ 07922.
What is the SIC code for Bio Green Med Solution, Inc. and what does it represent?
The Standard Industrial Classification (SIC) code for Bio Green Med Solution, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-09-17 16:53:39
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BGMS The Nasdaq Capital M
Filing Documents
- form8-ka.htm (8-K/A) — 39KB
- form8-ka_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-013902.txt ( ) — 267KB
- bgms-20250912.xsd (EX-101.SCH) — 4KB
- bgms-20250912_def.xml (EX-101.DEF) — 26KB
- bgms-20250912_lab.xml (EX-101.LAB) — 36KB
- bgms-20250912_pre.xml (EX-101.PRE) — 25KB
- form8-ka_htm.xml (XML) — 6KB
01
Item 8.01 Other Events Bio Green Med Solution, Inc. ( fka Cyclacel Pharmaceuticals, Inc.) has updated its logo to coincide with its new name and ticker symbol for its securities as previously announced on the Original Form 8-K.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 17, 2025 Bio Green Med Solution, Inc. By: /s/ Datuk Dr. Doris Wong Sing Ee Name: Datuk Dr. Doris Wong Sing Ee Title: Chief Executive Officer and Executive Director